Alaunos Therapeutics (TCRT) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to $1.9 million.
- Alaunos Therapeutics' Cash & Current Investments rose 1515.15% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 1515.15%. This contributed to the annual value of $1.1 million for FY2024, which is 8200.26% down from last year.
- Per Alaunos Therapeutics' latest filing, its Cash & Current Investments stood at $1.9 million for Q3 2025, which was up 1515.15% from $2.9 million recorded in Q2 2025.
- Alaunos Therapeutics' 5-year Cash & Current Investments high stood at $100.1 million for Q1 2021, and its period low was $319000.0 during Q1 2025.
- In the last 5 years, Alaunos Therapeutics' Cash & Current Investments had a median value of $18.3 million in 2023 and averaged $35.1 million.
- Over the last 5 years, Alaunos Therapeutics' Cash & Current Investments had its largest YoY gain of 1689.0% in 2025, and its largest YoY loss of 9230.4% in 2025.
- Alaunos Therapeutics' Cash & Current Investments (Quarter) stood at $76.1 million in 2021, then crashed by 30.32% to $53.0 million in 2022, then plummeted by 88.56% to $6.1 million in 2023, then plummeted by 82.0% to $1.1 million in 2024, then skyrocketed by 77.64% to $1.9 million in 2025.
- Its last three reported values are $1.9 million in Q3 2025, $2.9 million for Q2 2025, and $319000.0 during Q1 2025.